Congestive heart failure. New frontiers.
Authors:
Journal: The Western journal of medicine
Publication Type: Congress
Date: 1991
DOI: PMC1002791
ID: 1678903
Abstract
Congestive heart failure is a common syndrome with high mortality in its advanced stages. Current therapy includes the use of vasodilator drugs, which have been shown to prolong life. Despite current therapy, mortality remains high in patients with severe heart failure. Potent new inotropic vasodilators have improved ventricular performance but have not prolonged life in patients with end-stage heart failure. Serious arrhythmias are implicated in the sudden deaths of 30% to 40% of patients with severe heart failure, but the benefits of antiarrhythmic therapy have not been established. Upcoming trials will address this question. Ventricular remodeling and progressive dilatation after myocardial infarction commonly lead to congestive heart failure; early unloading of the ventricle with an angiotensin-converting enzyme inhibitor may attenuate these events. These findings support the concept that angiotensin-converting enzyme inhibitors may be useful in managing heart failure of all degrees of severity, including left ventricular dysfunction and end-stage heart failure. Part of the damage that may occur with acute myocardial infarction, particularly in this era of thrombolysis therapy, is reperfusion injury, which may be mediated by oxygen-derived free radicals. Better knowledge of the mechanisms and treatment of myocardial infarction, the leading cause of congestive heart failure, may help prevent or attenuate the development of this syndrome.
Chemical List
- Anti-Arrhythmia Agents|||Cardiotonic Agents|||Free Radicals
Reference List
- J Thorac Cardiovasc Surg. 1988 May;95(5):799-813|||Am J Cardiol. 1988 Apr 1;61(10):791-7|||J Am Coll Cardiol. 1988 Jan;11(1):12-9|||J Am Coll Cardiol. 1984 Nov;4(5):884-9|||Am Heart J. 1984 Nov;108(5):1278-84|||Br Heart J. 1984 Nov;52(5):530-5|||Am Heart J. 1987 Nov;114(5):1280-91|||Am J Cardiol. 1987 Feb 1;59(4):291-5|||N Engl J Med. 1986 Jun 12;314(24):1547-52|||Lab Invest. 1984 Dec;51(6):655-66|||J Am Coll Cardiol. 1986 Apr;7(4):729-42|||Circulation. 1986 Jan;73(1):14-8|||Am J Physiol. 1987 Sep;253(3 Pt 2):H709-11|||Am Heart J. 1987 Jul;114(1 Pt 1):1-7|||Circulation. 1987 Jul;76(1):52-8|||Am Heart J. 1987 May;113(5):1055-65|||J Am Coll Cardiol. 1987 May;9(5):989-95|||N Engl J Med. 1984 May 24;310(21):1357-62|||Circulation. 1983 Aug;68(2):446-52|||Am J Cardiol. 1983 Mar 1;51(5):802-10|||Circulation. 1983 Apr;67(4):829-36|||Am Heart J. 1980 Nov;100(5):622-30|||Circulation. 1982 Dec;66(6):1146-9|||Proc Natl Acad Sci U S A. 1980 Sep;77(9):5471-5|||Circulation. 1981 Dec;64(6):1150-6|||Am Heart J. 1981 Sep;102(3 Pt 2):555-63|||N Engl J Med. 1980 Oct 9;303(15):846-50|||Clin Pharmacol Ther. 1980 Sep;28(3):324-34|||Lancet. 1979 Jun 30;1(8131):1374-6|||Am J Cardiol. 1978 Feb;41(2):233-43|||Adv Exp Med Biol. 1977;78:67-82|||Am J Physiol. 1979 Mar;236(3):C103-10|||N Engl J Med. 1979 Jan 4;300(1):17-22|||Am J Cardiol. 1979 Jul;44(1):53-9|||Circulation. 1979 Mar;59(3):421-30|||N Engl J Med. 1979 Jan 11;300(2):57-62|||Circulation. 1978 Sep;58(3 Pt 1):466-75|||Am J Cardiol. 1978 Jun;41(7):1127-32|||Chest. 1977 Nov;72(5):618-22|||Circulation. 1977 Nov;56(5):786-94|||Biochem Pharmacol. 1974 Jul 1;23(13):1793-800|||N Engl J Med. 1974 Oct 3;291(14):707-10|||Am J Cardiol. 1973 Jun;31(6):701-7|||N Engl J Med. 1971 Dec 23;285(26):1441-6|||Circulation. 1967 Apr;35(4):614-30|||Fed Proc. 1987 May 15;46(7):2413-21|||Lancet. 1989 Jun 10;1(8650):1309-12|||J Am Coll Cardiol. 1989 Apr;13(5):1176-83|||J Am Coll Cardiol. 1989 Apr;13(5):1155-63|||Am J Cardiol. 1988 Aug 11;62(5):57C-62C|||Circulation. 1986 Dec;74(6):1424-33|||Circulation. 1987 Jun;75(6):1237-48|||N Engl J Med. 1988 Jul 14;319(2):80-6|||J Am Coll Cardiol. 1988 Nov;12(5):1318-25|||J Am Coll Cardiol. 1985 Jun;5(6):1355-62|||N Engl J Med. 1989 Mar 16;320(11):677-83|||Circulation. 1986 Jan;73(1):130-7|||Free Radic Biol Med. 1988;5(5-6):409-19|||Chest. 1987 Jul;92(1):118-23|||Circulation. 1989 May;79(5):1125-36|||Circulation. 1987 Jul;76(1):44-51|||N Engl J Med. 1987 Dec 24;317(26):1613-8|||Circulation. 1985 Aug;72(2):245-8|||Am Heart J. 1986 Apr;111(4):692-6|||J Clin Invest. 1988 Aug;82(2):476-85|||Am J Cardiol. 1987 Oct 1;60(10):934-6|||Circ Res. 1987 Jul;61(1):20-8|||N Engl J Med. 1985 Jan 17;312(3):159-63|||J Am Coll Cardiol. 1985 Jul;6(1):215-20|||Am J Cardiol. 1985 Sep 15;56(8):566-9|||J Am Coll Cardiol. 1987 Apr;9(4):849-57|||Am Heart J. 1987 Mar;113(3):707-15|||Am Heart J. 1986 Dec;112(6):1166-72|||Circulation. 1986 Oct;74(4):693-702|||Am J Physiol. 1986 Apr;250(4 Pt 2):H595-9|||Am Heart J. 1986 Sep;112(3):505-8|||Circ Res. 1986 Jan;58(1):148-56|||Circulation. 1986 Apr;73(4):740-8|||Circulation. 1985 Aug;72(2):406-12|||Circ Res. 1985 Jul;57(1):84-95|||Circulation. 1985 Dec;72(6):1327-35|||J Clin Invest. 1985 Nov;76(5):1713-9|||Am J Cardiol. 1985 Oct 1;56(10):672-7|||Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1539-44|||Am Heart J. 1985 Mar;109(3 Pt 1):497-504|||Circulation. 1978 Sep;58(3 Pt 1):449-60|||Prog Cardiovasc Dis. 1984 Jul-Aug;27(1):21-56|||Am J Cardiol. 1982 Apr 1;49(5):1120-6|||Annu Rev Biochem. 1983;52:159-86|||Hypertension. 1984 Jul-Aug;6(4):551-6|||Circulation. 1982 May;65(5):886-94|||Ann Intern Med. 1984 Sep;101(3):370-7|||J Am Coll Cardiol. 1983 Jan;1(1):82-9|||Eur J Pharmacol. 1984 Apr 6;99(4):345-7|||N Engl J Med. 1984 Sep 27;311(13):819-23|||N Engl J Med. 1983 Dec 15;309(24):1477-82|||Chest. 1983 Oct;84(4):408-13|||Am Heart J. 1983 Jul;106(1 Pt 1):100-6|||Am J Cardiol. 1984 Jun 25;53(13):9D-14D|||J Am Coll Cardiol. 1984 Aug;4(2):364-71|||Am J Med. 1984 Jun;76(6):999-1005|||J Am Coll Cardiol. 1984 Jun;3(6):1438-43|||Am J Cardiol. 1987 Aug 14;60(5):72C-74C|||West J Med. 1988 Nov;149(5):572-82|||J Am Coll Cardiol. 1988 Jul;12(1):274-83|||J Am Coll Cardiol. 1988 Jul;12(1):239-49|||Am J Physiol. 1989 Feb;256(2 Pt 2):H341-51|||Circulation. 1989 Jan;79(1):143-53|||Circ Res. 1989 Jan;64(1):86-96|||Lancet. 1988 Feb 6;1(8580):255-9|||J Am Coll Cardiol. 1988 Mar;11(3):614-23|||Am Heart J. 1988 Dec;116(6 Pt 1):1508-13|||N Engl J Med. 1988 Aug 4;319(5):257-62